AI assistant
CORCEPT THERAPEUTICS INC — Director's Dealing 2012
Apr 2, 2012
30681_dirs_2012-04-02_f68b48a1-f07c-4743-926b-6a1f299aa274.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2012-03-29
Reporting Person: ENRIGHT PATRICK G (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-03-29 | Common Stock | X | 856644 | $2.96 | Acquired | 13433573 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-03-29 | Warrants (Right to Buy) | $2.96 | X | 856644 | Disposed | 2013-04-21 | Common Stock (856644) | Indirect |
| 2012-03-29 | Warrants (Right to Buy) | $4.05 | P | 856644 | Acquired | 2014-03-20 | Common Stock (856644) | Indirect |
Footnotes
F1: Warrants exercised pursuant to a Warrant Purchase Agreement dated [March 29, 2012] (the "WPA"). Longitude Venture Partners, L.P. ("LVP") exercised 839,811 of the warrants described herein and Longitude Capital Associates, L.P. ("LCA") exercised 16,833 of the warrants described herein.
F2: Patrick G. Enright is a managing member of Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of each of LVP and LCA. LVP is the record holder of 839,811 shares of common stock and LCA is the record holder of 16,833 shares of common stock. Mr. Enright serves on the Board of Directors of the Issuer as the nominee of LVP. Mr. Enright disclaims beneficial ownership of the securities of the Issuer held, and previously reported, by Longitude Capital, LVP and LCA, except to the extent of his pecuniary interest therein.
F3: Warrants purchased pursuant to the WPA.
F4: LVP is the record holder of 839,811 of the warrants described herein and LCA is the record holder of 16,833 of the warrants described herein. Does not include warrants to purchase 2,261,418 shares of Common Stock beneficially owned by the reporting person and Longitude Capital, LVP, LCA and Juliet Tammenoms Bakker, in the aggregate. Such warrants have an exercise price equal to $2.77 per share and expire on March 24, 2015.